68 related articles for article (PubMed ID: 26111745)
1. Influence of Lentiviral β-Synuclein Overexpression in the Hippocampus of a Transgenic Mouse Model of Alzheimer's Disease on Amyloid Precursor Protein Metabolism and Pathology.
Krassnig S; Schweinzer C; Taub N; Havas D; Auer E; Flunkert S; Schreibmayer W; Hutter-Paier B; Windisch M
Neurodegener Dis; 2015; 15(4):243-57. PubMed ID: 26111745
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
Leitão ADG; Spencer B; Sarsoza F; Ngolab J; Amalraj J; Masliah E; Wu C; Rissman RA
J Alzheimers Dis; 2023; 95(1):349-361. PubMed ID: 37522208
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies.
Overk CR; Cartier A; Shaked G; Rockenstein E; Ubhi K; Spencer B; Price DL; Patrick C; Desplats P; Masliah E
Mol Neurodegener; 2014 May; 9():18. PubMed ID: 24885390
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of synucleins by members of the Polo-like kinase family.
Mbefo MK; Paleologou KE; Boucharaba A; Oueslati A; Schell H; Fournier M; Olschewski D; Yin G; Zweckstetter M; Masliah E; Kahle PJ; Hirling H; Lashuel HA
J Biol Chem; 2010 Jan; 285(4):2807-22. PubMed ID: 19889641
[TBL] [Abstract][Full Text] [Related]
5. Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease.
Leitão ADG; Ahammad RU; Spencer B; Wu C; Masliah E; Rissman RA
Neurobiol Dis; 2023 Oct; 186():106285. PubMed ID: 37690676
[TBL] [Abstract][Full Text] [Related]
6. Special Issue "Neurobiology of Protein Synuclein".
Toni M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542197
[TBL] [Abstract][Full Text] [Related]
7. Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques.
Gowrishankar S; Yuan P; Wu Y; Schrag M; Paradise S; Grutzendler J; De Camilli P; Ferguson SM
Proc Natl Acad Sci U S A; 2015 Jul; 112(28):E3699-708. PubMed ID: 26124111
[TBL] [Abstract][Full Text] [Related]
8. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model.
Fang D; Wang Y; Zhang Z; Du H; Yan S; Sun Q; Zhong C; Wu L; Vangavaragu JR; Yan S; Hu G; Guo L; Rabinowitz M; Glaser E; Arancio O; Sosunov AA; McKhann GM; Chen JX; Yan SS
Hum Mol Genet; 2015 Sep; 24(18):5198-210. PubMed ID: 26123488
[TBL] [Abstract][Full Text] [Related]
9. Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse.
Song LK; Ma KL; Yuan YH; Mu Z; Song XY; Niu F; Han N; Chen NH
PLoS One; 2015; 10(6):e0131281. PubMed ID: 26114655
[TBL] [Abstract][Full Text] [Related]
10. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.
Dorresteijn B; Rotman M; Faber D; Schravesande R; Suidgeest E; van der Weerd L; van der Maarel SM; Verrips CT; El Khattabi M
FEBS J; 2015 Sep; 282(18):3618-31. PubMed ID: 26147692
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-related protein 3 is a potential Aβ-associated protein in Alzheimer's Disease.
Bruggink KA; Kuiperij HB; Gloerich J; Otte-Höller I; Rozemuller AJ; Claassen JA; Küsters B; Verbeek MM
J Neurochem; 2015 Sep; 134(6):1152-62. PubMed ID: 26119087
[TBL] [Abstract][Full Text] [Related]
12. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
[TBL] [Abstract][Full Text] [Related]
13. SorCS1 variants and amyloid precursor protein (APP) are co-transported in neurons but only SorCS1c modulates anterograde APP transport.
Hermey G; Schmidt N; Bluhm B; Mensching D; Ostermann K; Rupp C; Kuhl D; Kins S
J Neurochem; 2015 Oct; 135(1):60-75. PubMed ID: 26119586
[TBL] [Abstract][Full Text] [Related]
14. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
Alcolea D; Martínez-Lage P; Sánchez-Juan P; Olazarán J; Antúnez C; Izagirre A; Ecay-Torres M; Estanga A; Clerigué M; Guisasola MC; Sánchez Ruiz D; Marín Muñoz J; Calero M; Blesa R; Clarimón J; Carmona-Iragui M; Morenas-Rodríguez E; Rodríguez-Rodríguez E; Vázquez Higuera JL; Fortea J; Lleó A
Neurology; 2015 Aug; 85(7):626-33. PubMed ID: 26180139
[TBL] [Abstract][Full Text] [Related]
15. Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability.
Fourier A; Portelius E; Zetterberg H; Blennow K; Quadrio I; Perret-Liaudet A
Clin Chim Acta; 2015 Sep; 449():9-15. PubMed ID: 26141614
[TBL] [Abstract][Full Text] [Related]
16. In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease.
Cui J; Zufferey V; Kherif F
Curr Opin Neurol; 2015 Aug; 28(4):351-7. PubMed ID: 26132531
[TBL] [Abstract][Full Text] [Related]
17. Cyclic Ozone Exposure Induces Gender-Dependent Neuropathology and Memory Decline in an Animal Model of Alzheimer's Disease.
Akhter H; Ballinger C; Liu N; van Groen T; Postlethwait EM; Liu RM
Toxicol Sci; 2015 Sep; 147(1):222-34. PubMed ID: 26116027
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of GSK3β by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's disease.
Noel A; Ingrand S; Barrier L
Exp Neurol; 2015 Sep; 271():308-18. PubMed ID: 26115843
[TBL] [Abstract][Full Text] [Related]
19. Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice.
Morris M; Knudsen GM; Maeda S; Trinidad JC; Ioanoviciu A; Burlingame AL; Mucke L
Nat Neurosci; 2015 Aug; 18(8):1183-9. PubMed ID: 26192747
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.
Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C
Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
